| Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer M Kobayashi, K Sawada, M Miyamoto, A Shimizu, M Yamamoto, Y Kinose, ... Biochemical and biophysical research communications 527 (1), 153-161, 2020 | 85 | 2020 |
| Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types M Kobayashi, K Sawada, K Nakamura, A Yoshimura, M Miyamoto, ... Journal of ovarian research 11, 1-10, 2018 | 74 | 2018 |
| Role of the exosome in ovarian cancer progression and its potential as a therapeutic target K Nakamura, K Sawada, M Kobayashi, M Miyamoto, A Shimizu, ... Cancers 11 (8), 1147, 2019 | 69 | 2019 |
| Exosomal CD47 plays an essential role in immune evasion in ovarian cancer A Shimizu, K Sawada, M Kobayashi, M Yamamoto, T Yagi, Y Kinose, ... Molecular Cancer Research 19 (9), 1583-1595, 2021 | 53 | 2021 |
| Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression K Nakamura, K Sawada, M Miyamoto, Y Kinose, A Yoshimura, K Ishida, ... Oncotarget 10 (6), 673, 2019 | 32 | 2019 |
| Pathophysiological role and potential therapeutic exploitation of exosomes in ovarian cancer A Shimizu, K Sawada, T Kimura Cells 9 (4), 814, 2020 | 25 | 2020 |
| Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells M Miyamoto, K Sawada, K Nakamura, A Yoshimura, K Ishida, ... Scientific Reports 10 (1), 16755, 2020 | 15 | 2020 |
| Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study M Kobayashi, K Sawada, A Yoshimura, M Yamamoto, A Shimizu, ... BMC Women's Health 20, 1-8, 2020 | 9 | 2020 |
| Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types. J … M Kobayashi, K Sawada, K Nakamura, A Yoshimura, M Miyamoto, ... | 7 | |
| Development of novel approaches to detect ovarian cancer recurrence A Shimizu, K Sawada, T Kimura Journal of Medical Artificial Intelligence 2, 2019 | 4 | 2019 |
| Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers A Shimizu, K Sawada, M Shiomi, M Kawano, Y Matsumoto, T Takiuchi, ... International Journal of Gynecology & Obstetrics 147 (2), 252-257, 2019 | 3 | 2019 |
| Continuous administration of anti-VEGFA antibody upregulates PAI-1 secretion from ovarian cancer cells via miR-143-3p downregulation T Yagi, K Sawada, M Miyamoto, A Shimizu, Y Oi, A Toda, K Nakamura, ... Molecular Cancer Research 21 (10), 1093-1106, 2023 | 1 | 2023 |
| Direct oral anticoagulants are effective and safe in patients with gynecologic cancer A Shimizu, K Sawada, M SHiomi, M Kawano, T Takiuchi, M Yuri, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28, 564-564, 2018 | 1 | 2018 |
| Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment A Shimizu, K Sawada, M Kobayashi, Y Oi, T Oride, Y Kinose, M Kodama, ... Cancers 16 (8), 1482, 2024 | | 2024 |
| Abstract B036: Spatial transcriptomics reveals stepwise biomolecular changes in ovarian cancer tumor microenvironments A Shimizu, R Krishnan, L Schweizer, L Kelliher, E Lengyel Cancer Research 84 (5_Supplement_2), B036-B036, 2024 | | 2024 |
| Abstract A107: Characterizing the genomic and immunologic landscape of serous borderline tumors and low-grade serous ovarian cancer R Krishnan, A Bilecz, P Herbst, A Shimizu, L Schweizer, E Jaeger, ... Cancer Research 84 (5_Supplement_2), A107-A107, 2024 | | 2024 |
| Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression L Schweizer, R Krishnan, A Shimizu, A Metousis, H Kenny, R Mendoza, ... medRxiv, 2023 | | 2023 |
| High-depth multi-omics analysis defines the transition of borderline, micropapillary and low-grade serous cancers (2310) R Krishnan, L Schweizer, A Shimizu, A Metousis, A Bilecz, R Mendoza, ... Gynecologic Oncology 176, S321-S322, 2023 | | 2023 |
| Decoding evolutionary trajectories of ovarian cancer metastasis A Shimizu, E Lengyel Cancer Cell 41 (6), 1008-1010, 2023 | | 2023 |
| Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study) T Oride, K Sawada, A Shimizu, Y Kinose, T Takiuchi, M Kodama, ... Thrombosis Journal 21 (1), 57, 2023 | | 2023 |
